Basis of abdominal pain and neuropsychiatric disorders in acute intermittent porphyria
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Loading Image
Reading File
Finding Sources
Loading Image
Finding Sources
Finding Sources
Reading File
Finding Sources
Loading Image
Finding Sources
I have enough information from the textbooks to provide a comprehensive, well-structured answer. Let me now compile the complete response.
Basis of Abdominal Pain and Neuropsychiatric Disorders in Acute Intermittent Porphyria (AIP)
Background: The Enzyme Defect
AIP is an autosomal dominant disorder caused by a deficiency of porphobilinogen (PBG) deaminase (also called hydroxymethylbilane synthase, HMBS) - the third enzyme in the heme biosynthetic pathway. This results in the accumulation of two key toxic precursors upstream: delta-aminolevulinic acid (ALA) and porphobilinogen (PBG), which are excreted in large amounts in the urine during acute attacks. Over 240 mutations have been identified in PBG deaminase. - Yamada's Textbook of Gastroenterology, 7th Ed.
The buildup occurs primarily in the liver (the major site of non-erythroid heme synthesis), and is greatly amplified when ALAS1 (the first and rate-limiting enzyme) is induced by drugs (barbiturates, sulfonamides, griseofulvin, estrogens, phenytoin), fasting, or hormonal changes. - Harper's Illustrated Biochemistry, 32nd Ed.
1. Basis of Abdominal Pain
The abdominal pain in AIP is the most common and often the first symptom of an acute attack - typically described as severe, colicky, diffuse or generalized, without abdominal wall rigidity or tenderness. It can last for days to weeks.
Mechanisms:
A. Autonomic Neuropathy (primary mechanism)
Accumulated ALA and PBG cause a visceral autonomic neuropathy affecting the enteric and autonomic nervous system. This leads to:
- Dysmotility, constipation, and intestinal distention (ileus)
- Severe visceral pain via disordered gut motility and smooth muscle dysfunction
- Tachycardia and hypertension (sympathetic overactivity)
- Urinary retention and incontinence
This is the most widely accepted mechanism - the abdominal pain is neurogenic in origin, not from structural gut pathology. - Adams and Victor's Principles of Neurology, 12th Ed.
B. ALA as a Direct Neurotoxin
ALA structurally resembles GABA and can act at GABA receptors, disrupting normal inhibitory neurotransmission in visceral afferents and autonomic ganglia. This is proposed to mediate both the pain and the neuropsychiatric features (see below). - Bradley and Daroff's Neurology in Clinical Practice
C. Sympathetic Hyperactivity
Dysautonomia produces marked sympathetic overactivity - tachycardia, hypertension, and possibly direct smooth muscle spasm of the gut - contributing to colicky pain. - Harrison's Principles of Internal Medicine, 22nd Ed.
D. Heme Deficiency in Neural Tissue
Reduced heme synthesis impairs heme-dependent enzymes in neural tissue (including mitochondrial respiratory chain complexes and tryptophan pyrrolase). Recent studies found decreased mitochondrial oxygen consumption rates in peripheral blood mononuclear cells of AIP patients, suggesting ATP deficiency in neural tissue as a contributing mechanism. - Bradley and Daroff's Neurology in Clinical Practice
2. Basis of Neuropsychiatric Disorders
Neuropsychiatric manifestations in AIP include:
- Psychiatric: psychosis, delirium/confusion, agitation, hallucinations, depression, anxiety, apathy
- CNS: seizures, visual field defects (e.g., homonymous hemianopia), encephalopathy
- Peripheral nervous system: mainly motor polyneuropathy (axonal), ascending or proximal weakness mimicking Guillain-Barre syndrome; sensory loss in ~50%
Mechanisms:
A. ALA as a GABA Structural Analogue (key proposed mechanism)
ALA has a close structural resemblance to gamma-aminobutyric acid (GABA). It is proposed to:
- Act as a partial agonist or competitive inhibitor at GABA-A receptors, disrupting inhibitory neurotransmission throughout the CNS and peripheral nervous system
- Produce excitotoxic and disinhibitory effects, resulting in psychosis, seizures, and delirium
- Interfere with GABA-mediated autonomic signaling
This is one of the most cited mechanisms for the psychiatric symptoms. - Bradley and Daroff's Neurology in Clinical Practice
B. ALA and PBG Direct Neurotoxicity
Both ALA and PBG are directly neurotoxic to peripheral and central neurons:
- Accumulation in CSF and neural tissue causes axonal degeneration in peripheral nerves
- Electrophysiology (EDx) shows markedly reduced CMAP amplitudes and signs of active axonal degeneration - Harrison's Principles of Internal Medicine, 22nd Ed.
- Pathologically, in fatal cases: myelinated fibers appear initially normal, but after weeks show degeneration of both axons and myelin sheaths in most peripheral nerves - Adams and Victor's Principles of Neurology, 12th Ed.
C. Heme Deficiency in Neurons
Neurons require heme for:
- Cytochrome oxidase (mitochondrial energy production)
- Tryptophan metabolism (precursor to serotonin and NAD)
- P450 enzymes A deficiency of heme in neural tissue impairs mitochondrial function and may cause neuronal energy failure, axonal degeneration, and psychiatric disturbances. - Bradley and Daroff's Neurology in Clinical Practice
D. Hyponatremia (SIADH)
During acute attacks, inappropriate ADH secretion causes hyponatremia, which itself precipitates:
- Seizures
- Delirium/confusion
- Encephalopathy
This is an important secondary mechanism for neuropsychiatric features. - Harrison's Principles of Internal Medicine, 22nd Ed.
E. Cerebral Vasospasm
The autonomic dysfunction with hypertension and sympathetic overactivity can produce cerebral vasoconstriction, contributing to encephalopathy, visual field defects, and seizures via posterior reversible encephalopathy syndrome (PRES)-like mechanisms.
Summary Table
| Feature | Mechanism |
|---|---|
| Abdominal pain | Autonomic neuropathy → gut dysmotility; ALA neurotoxicity to visceral nerves |
| Constipation/ileus | Enteric neuropathy, loss of coordinated peristalsis |
| Psychosis/hallucinations | ALA acting as GABA analogue; direct ALA/PBG neurotoxicity |
| Seizures | ALA-GABA disruption; hyponatremia (SIADH); encephalopathy |
| Motor polyneuropathy | Axonal degeneration from heme-dependent enzyme deficiency; ALA toxicity |
| Tachycardia/hypertension | Sympathetic hyperactivity from autonomic neuropathy |
| Confusion/delirium | Hyponatremia; cerebral ALA toxicity; mitochondrial dysfunction |
Key Point: The Pathogenesis is Multifactorial
As noted in Harrison's and Adams and Victor's, "the relation between the abnormality of porphyrin biosynthesis in the liver and nervous dysfunction has never been explained satisfactorily." Multiple mechanisms are likely operative simultaneously - ALA neurotoxicity (GABA-like action), heme deficiency in neural tissue, mitochondrial dysfunction, and dysautonomia all probably contribute. - Adams and Victor's Principles of Neurology, 12th Ed.; Harrison's Principles of Internal Medicine, 22nd Ed.
The therapeutic effectiveness of givosiran (siRNA silencing ALAS1, reducing ALA/PBG production) and intravenous hematin (repressing ALAS1 via heme feedback) confirms that ALA/PBG accumulation is causally central to both the abdominal and neuropsychiatric manifestations. - Bradley and Daroff's Neurology; Harrison's 22nd Ed.
This is a shared conversation. Sign in to Orris to start your own chat.